| |
|
|
| |
Prefilled Syringes to 2018
Devices, Drugs, Markets, Players and
Prospects
|
Publication: March 2013
Product Code: PSJ169F
Drug Delivery Reports
|
The administration of therapeutic drugs via injection is an
indispensable delivery method for numerous drugs critical to
patient health and well-being. Now this segment is evolving
in response to changing patient populations, new classes of
powerful therapeutic drugs and healthcare administration
initiatives. Population demographics and efforts by managed
care providers to control healthcare costs are driving the
growth in drug self-administration, particularly for chronic
conditions, introducing a new class of naïve users to
parenteral drug delivery. For Fill-and-Finish contractors,
market proximity is an important competitive factor. As the
use of prefilled syringes continues to grow, the issue of
prefilled syringe safety has received increased attention,
with both integrated prefillable safety syringes and safety
solutions designed to accommodate existing prefillable
syringes advancing commercially. This report analyzes eleven
important prefilled syringe therapeutic segments and
examines key regulatory, economic and competitive factors
that represent potential barriers to commercial success.
|
|
Highlights |
· Provides detailed
analysis of prefilled syringe market segments, market
dynamics and market demographics
· Analyzes therapeutic
demand drivers and evaluates commercial prefilled
syringe products in eleven major therapeutic segments
· Examines design factors,
material selection issues, technologies and market
development issues
· Charts product data,
market share, and forecasts to 2018
· Profiles injectable drug
and device participants, their product development
activities, business strategies, and corporate alliances
and affiliations
|
|
Table of Contents |
Executive Summary
Injectable Drug Market
Dynamics
Competitive Landscape
The Device
Manufacturing Universe
Supply Chain Dynamics
Supply Chain Structure
Supplier Relationships and
Supply Risk
Supplier Integration
Captive
Capacity vs CMOs
Demand Drivers
Drug Discovery
and Development Trends
Patient and Caregiver
Sentiment
Diseases and Indications
Patient
Demographics
The Prefilled Syringe Ecosystem
and Supply Chain
Materials and Components
Evolving Technology
Alliances & Relationships
Syringe Manufacturers
Technology/Capabilities
Geographic Reach
Barriers to Entry
CMO’s –
Beyond Fill & Finish
Value-added Services
Market Proximity
CMO Evolution
Testing,
Services and Validation
Prefilled Syringes –
Design Factors
Drug Stability and Shelf Life
Material Selection Issues
Point-of-Use
Reconstitution
Caregiver Safety
Needle
Configuration Strategies
Human
Engineering/Ergonomics
Prefilled Syringes –
Commercial Devices
Prefillable Therapeutic
Injectables
Glass Prefillable Syringes
Plastic
Prefillable Syringes
Ready-to-Fill Safety
Syringes
Specialty Prefillable Syringes
Flush Syringes
Diluent Syringes
Imaging Agent
Syringes
Competing Prefilled Devices
Bundled PFS + Autoinjector
Prefilled Pen
Injectors
Prefilled Needle-free Injectors
Prefilled Syringe Market Segments
Prefilled
Therapeutic Injectables
Anaphylaxis
Anticoagulants
Autoimmune Diseases
Emergency
Medicine
Hepatitis
Hematopoietics and Related
Erythropoiesis Stimulating Proteins
Metabolic
Diseases
Neurology
Reproductive Health
Vaccines
Non-API Prefilled Syringe Segments
Catheterization
Reconstitution
Diagnostic
Imaging
Market Factors
Self-Administration and Patient Compliance
Insurance, Reimbursement, and Managed Care
Regulatory Guidance and Product Approvals
The
Evolving PFS Ecosystem
Prefilled Syringes –
Market Participant Profiles |
|
|
|
|
